NimbleGen Secures Additional $1.5M in Series B Round | GenomeWeb

NEW YORK, Oct. 17 – NimbleGen Systems has added $1.5 million in a second closing of its Series B financing round, the company said on Wednesday. A $9 million first closing was announced on Sept. 11, and the recent cash infusion brings to $14 million NimbleGen’s total funds raised to date.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.